Martin Blüggel, Chief Executive Officer (CEO)
Martin Blüggel is a graduate in chemistry (Dipl.-Chem) and an expert in Protein Analytics, Bioinformatics and Biosimilars. Since 1997, he has been active in R&D, Business Development and Management at Protagen Protein Services GmbH. He is co-founder of Protagen in 1997.
Dr. Roland Moussa, Chief Operating Officer (COO)
Roland Moussa studied Bioinformatics, Genome Research and Biotechnology and is an expert for protein characterization. After heading lab teams and successfully managing several drug development projects he was site manager for a CRO and joined PPS in 2015. Since 2020 he serves as COO.
Pedro Schuermann, Chief Financial Officer (CFO)
Pedro Schuermann studied economics and business administration. His international career spans positions in investment banking, private equity, financial management and corporate development across several service industries, notably in the life sciences / laboratory services area.
Kirtland Poss, President & CEO Bioanalytix, Inc.
Kirtland Poss holds a Bachelor of Arts degree. He started his career in research at the Massachussets General Hospital and Harvard Medical School, and has worked in the business field of biomarker imaging and pharmaceutical development since 2000. Prior to BioAnalytix he founded and ran the molecular imaging company VisEn Medical, which was acquired by Perkin Elmer in 2010. In 2012 he founded BioAnalytix and has served as President and CEO since then.
Protagen Protein Services (PPS) is a world leading CRO and recognized expert for analytical services in protein science. More than 20 years of market experience and the comprehensive spectrum of validated analytical methods ensure the highest quality for customers in the pharmaceutical, biotech and life science industry.
PPS supports Biosimilar developers with a broad range of analytical methods and consulting in achieving and demonstrating Biosimilarity